Company / PP&E per Share
Monte Rosa Therapeutics, Inc. PP&E per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.40
FY2024
5-year range
$0.40 / $3.05
FY2020-FY2024
Trend
-39.3%
vs FY2023
Sector context
#61 of 191
Health Care
What the data says
At $0.40, Monte Rosa Therapeutics, Inc.'s pp&e per share ranks #61 of 191 in the Health Care sector. Declined from $0.57 to $0.40 over the past 2 years.
Based on SEC 10-K filings.
0.40 in FY2024 with a 3-year CAGR of -6.8%.
Declined from $0.57 to $0.40 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -6.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#61 of 191 in Health CareTop 32% of 191This company $0.40 Sector average $22.34
▼
-98.2% below sector average
Key checks
Key Insights
- In FY2024, pp&e per share decreased 39.3% year-over-year.
- Ranks #61 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.40 | -39.3% |
| FY2023 | $0.66 | +14.7% |
| FY2022 | $0.57 | +16.3% |
| FY2021 | $0.49 | -83.8% |
| FY2020 | $3.05 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026